Abstract | OBJECTIVE: DESIGN: A 3-month, controlled, randomized, double-masked, multicenter, clinical trial. Patients were randomized to 2% dorzolamide 3 times daily or timolol maleate gel-forming solution (0.25% for patients <2 years and 0.5% for patients > or =2 but <6 years) once daily plus placebo twice daily. If the intraocular pressure was not controlled through monotherapy, younger patients received concomitant dorzolamide 3 times daily and 0.25% timolol gel-forming solution once daily and older patients received a fixed combination of 2% dorzolamide and 0.5% timolol twice daily. The primary safety variable was the proportion of patients who discontinued therapy for a drug-related adverse experience. Intraocular pressure reduction was a secondary measure. RESULTS: One younger patient (1.8%) of 56 randomized to dorzolamide discontinued concomitant therapy because of bradycardia. Two older patients (3.0%) of 66 discontinued dorzolamide because of ocular adverse experiences. The most frequent ocular adverse experiences were discharge and ocular hyperemia (younger cohort) and ocular hyperemia and burning/stinging (older cohort). At week 12, the mean change in intraocular pressure for dorzolamide was statistically significant from baseline (-7.3 mm Hg [-20.6%] and -7.1 mm Hg [-23.3%]) in the younger and older cohorts, respectively; P<.001 for both. CONCLUSION:
Dorzolamide was generally well tolerated and demonstrated efficacy for up to 3 months in patients younger than 6 years.
|
Authors | Elyssa Z Ott, Monte D Mills, Santiago Arango, Albert J Getson, Christopher A Assaid, Ingrid A Adamsons |
Journal | Archives of ophthalmology (Chicago, Ill. : 1960)
(Arch Ophthalmol)
Vol. 123
Issue 9
Pg. 1177-86
(Sep 2005)
ISSN: 0003-9950 [Print] United States |
PMID | 16157797
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antihypertensive Agents
- Ophthalmic Solutions
- Sulfonamides
- Thiophenes
- Timolol
- dorzolamide
|
Topics |
- Antihypertensive Agents
(administration & dosage, adverse effects)
- Child, Preschool
- Double-Blind Method
- Female
- Glaucoma
(drug therapy, etiology)
- Humans
- Infant
- Intraocular Pressure
(drug effects)
- Male
- Ocular Hypertension
(drug therapy)
- Ophthalmic Solutions
(administration & dosage)
- Prospective Studies
- Safety
- Sulfonamides
(administration & dosage, adverse effects)
- Thiophenes
(administration & dosage, adverse effects)
- Timolol
(administration & dosage, adverse effects)
- Treatment Outcome
|